Term
|
Definition
|
|
Term
|
Definition
| This drug targets Alpha-1, Alpha-2, Beta-1, Beta-2, Beta-3 receptors |
|
|
Term
|
Definition
| This drug targets Alpha-1, Alpha-2, Beta-1 receptors |
|
|
Term
|
Definition
| This drug targets Beta-1, Beta-2, Beta-3 receptors |
|
|
Term
|
Definition
| This drug targets Alpha-1 receptors |
|
|
Term
| Oxymetazoline and Brimonidine targets |
|
Definition
| This drug targets Alpha-2 receptors in the peripheral nervous system |
|
|
Term
| Clonidine and Guanfacine targets |
|
Definition
| This drug targets Alpha-2 receptors in the CNS |
|
|
Term
|
Definition
| This drug targets Beta-1 receptors |
|
|
Term
| Albuterol, Terbutaline, Salmetertol targets |
|
Definition
| This drug targets Beta-2 receptors |
|
|
Term
|
Definition
| This drug targets Beta-3 receptors |
|
|
Term
|
Definition
| This drug is metabolized by MAO and COMT (1) |
|
|
Term
| Norepinephrine metabolism |
|
Definition
| This drug is metabolized by MAO and COMT (2) |
|
|
Term
| Norepinephrine cardiovascular actions |
|
Definition
| This drug causes Decreased HR, Increased BP, Increased Peripheral Resistance (1) |
|
|
Term
| Phenylephrine cardiovascular actions |
|
Definition
| This drug causes Decreased HR, Increased BP, Increased Peripheral Resistance (2) |
|
|
Term
| Norepinephrine vs. Phenylephrine (magnitude of cardio response) |
|
Definition
| Phenylephrine causes a larger response than norepinephrine |
|
|
Term
| Isoproterenol cardiovascular actions |
|
Definition
| This drug causes Increased HR, Decreased mean/diastolic BP, Increased systolic BP, and Decreased Peripheral Resistance |
|
|
Term
| Drugs that stimulate release of norepinephrine from sympathetic nerves |
|
Definition
| Amphetamine, methamphetamine, Methylphenidate, phentermine, Tyramine |
|
|
Term
| Drugs that block neuronal uptake of norepinephrine |
|
Definition
| Tricyclic antidepressants (desipramine, Imipramine) and cocaine |
|
|
Term
| Mixed acting sympathomimetic drugs |
|
Definition
| ephedrine, Pseudoephedrine |
|
|
Term
| Tyramine + this drug is dangerous |
|
Definition
| This drug with Phenelzine, is dangerous |
|
|
Term
|
Definition
| This drug stimulates release of norepinephrine |
|
|
Term
|
Definition
| This drug blocks the action of MAO |
|
|
Term
|
Definition
| This drug blocks reupate of norepinephrine |
|
|
Term
|
Definition
| This drug stimulates release of norepinephrine in addition to stimulating the adrenoceptors |
|
|
Term
| Drug for treating cardiac arrest |
|
Definition
| Epinephrine is helpful in treating |
|
|
Term
| Drug for treating cardiogenic shock |
|
Definition
| Dobutamine and Dopamine is helpful in treating |
|
|
Term
| Drug for treating arrhythmias |
|
Definition
| Phenylephrine is helpful in treating (1) |
|
|
Term
| Drug for treating hypotension |
|
Definition
| Phenylephrine is helpful in treating (2) |
|
|
Term
| Drug for treating bronchoconstriction |
|
Definition
| Albuterol is helpful in treating |
|
|
Term
| Drug for treating nasal congestion |
|
Definition
| Pseudoephedrine, Phenylephrine, Oxymatazoline is helpful in treating |
|
|
Term
| Drug for treating wide/open angle glaucoma |
|
Definition
| Epinephrine and Brimonidine is helpful in treating |
|
|
Term
| Drug for treating congestion in the eye |
|
Definition
| Tetrahydrozoline is helpful in treating |
|
|
Term
| Drug for treating overactive bladder |
|
Definition
| Mirabegron is helpful in treating |
|
|
Term
|
Definition
| Amphetamine and Methylphenidate treat this by increasing dopamine and norepinephrine in prefrontal cortex |
|
|
Term
| Drug for treating obesity |
|
Definition
| Phentermine treats this by suppresing appetite by increasing norepinephrine, dopamine, and serotonin in the CNS |
|
|
Term
| Drug for treating depression |
|
Definition
| Tricyclic antidepressants (desipramine, Imipramine) treat this by blocking neuronal uptake of norepinephrine and/or serotonin in the CNS |
|
|
Term
| Cardiovascular adverse effects of sympathomimetics |
|
Definition
| Palpitations/tachycardia/ischemia/angina (beta-1 > beta-2 drugs), increased BP, and bradycardia from (alpha-1 and alpha-2 drugs) |
|
|
Term
| Genitourinary adverse effects of sympathomimetics |
|
Definition
| Urinary retention (from alpha-1 drugs) |
|
|
Term
| CNS adverse effects of sympathomimetics |
|
Definition
| Stimulation (indirect > mixed > direct acting drugs) |
|
|
Term
| Skeletal muscle adverse effects of sympathomimetics |
|
Definition
| Tremors (Beta-2 > Beta-1 drugs) |
|
|
